Delivery Order SPE2DR25D2104-SPE2DR26F3NEP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Duloxetine HCl 60 mg capsules (30-count packages) on November 4, 2025, with a ceiling value of $5,515.84 and an ultimate completion date of November 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units) with a ceiling value of $3,245.94. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (60-count units) valued at $1,688.88. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a ceiling value of $1,129.80. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, represents a non-competitive set-aside award to support federal pharmaceutical procurement needs. The product will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 count) with a ceiling value of $2,007.74. This firm fixed-price delivery order, which is expected to be completed by September 25, 2025, utilizes no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a straightforward pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,320.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The order has an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.80 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count) on August 15, 2025, with completion expected by August 18, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 1,000 units of Duloxetine HCL DR 20 mg capsules at a ceiling value of $1,235.18. This contract was awarded without a set-aside designation through open competition and is scheduled for completion by September 24, 2025. The delivery location is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.07 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCl DR 20 mg capsules. This order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NEPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (90-count units) with a ceiling value of $2,910.80. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is scheduled for completion by November 5, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader $999,999,999 IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen regularly fulfills delivery orders for neurological, pain management, diabetes, and other therapeutic medications to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded, firm fixed-price contracts demonstrates its established capability to meet federal pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/4/25 |